Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
BMC Public Health|January 29, 2025
Mortality in the families of children during the COVID-19 pandemic: evidence from a repeated cross-sectional study of children in the United StatesKao-Ping Chua, Rena M Conti, Nora V Becker
Journal of Law and the Biosciences|September 16, 2024
Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyondHolly Fernandez Lynch, Rena M Conti, Jorge L Contreras
JAMA Network Open|October 18, 2021
Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|October 22, 2016
Pharmaceuticals and Public HealthRena M Conti, Rebekah E Gee, Joshua M Sharfstein
The Milbank Quarterly|June 18, 2005
Mental health policy and psychotropic drugsRichard G Frank, Rena M Conti, Howard H Goldman
Annals of Hematology|March 28, 2015
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EURena M Conti, William V Padula, Richard A Larson
JAMA Network Open|October 31, 2019
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016Rena M Conti, Sayeh S Nikpay, Melinda B Buntin
JAMA Network Open|February 14, 2022
Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021Kao-Ping Chua, Rena M Conti, Nora V Becker
The New England Journal of Medicine|April 22, 2024
The Myth of the Free Market for PharmaceuticalsRena M Conti, Richard G Frank, David M Cutler
Journal of Pharmaceutical Policy and Practice|November 28, 2018
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?Rena M Conti, Kevin H Nguyen, Meredith B Rosenthal
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
BMC Public Health|January 29, 2025
Mortality in the families of children during the COVID-19 pandemic: evidence from a repeated cross-sectional study of children in the United StatesKao-Ping Chua, Rena M Conti, Nora V Becker
Journal of Law and the Biosciences|September 16, 2024
Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyondHolly Fernandez Lynch, Rena M Conti, Jorge L Contreras
JAMA Network Open|October 18, 2021
Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|October 22, 2016
Pharmaceuticals and Public HealthRena M Conti, Rebekah E Gee, Joshua M Sharfstein
The Milbank Quarterly|June 18, 2005
Mental health policy and psychotropic drugsRichard G Frank, Rena M Conti, Howard H Goldman
Annals of Hematology|March 28, 2015
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EURena M Conti, William V Padula, Richard A Larson
JAMA Network Open|October 31, 2019
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016Rena M Conti, Sayeh S Nikpay, Melinda B Buntin
JAMA Network Open|February 14, 2022
Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021Kao-Ping Chua, Rena M Conti, Nora V Becker
The New England Journal of Medicine|April 22, 2024
The Myth of the Free Market for PharmaceuticalsRena M Conti, Richard G Frank, David M Cutler
Journal of Pharmaceutical Policy and Practice|November 28, 2018
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?Rena M Conti, Kevin H Nguyen, Meredith B Rosenthal
Pageof 14